QIPT — Quipt Home Medical Cashflow Statement
0.000.00%
Last trade - 00:00- CA$213.31m
- CA$374.39m
- $245.36m
- 62
- 85
- 74
- 87
Annual cashflow statement for Quipt Home Medical, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2021 September 30th | 2022 September 30th | C2023 September 30th | 2024 September 30th | 2025 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | USG | — | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.17 | 4.84 | -2.78 | -6.76 | -10.7 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 19.8 | 0.367 | 6.22 | 3.75 | 3.91 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -8.88 | -1.9 | -2.01 | -6.53 | -1.08 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 18.7 | 26.3 | 37 | 35.4 | 37.7 |
| Capital Expenditures | -5.05 | -9.16 | -6.85 | -10.3 | -12.4 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -12.8 | -33.3 | -76 | 0 | -20.6 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -17.8 | -42.5 | -82.8 | -10.3 | -32.9 |
| Financing Cash Flow Items | -1.27 | -4.92 | -6.42 | -1.16 | -0.079 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 3.91 | -9.85 | 54.4 | -26.1 | -7.76 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.38 | -26.1 | 8.69 | -1.03 | -3.26 |